-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Equal-Weight on West Pharmaceutical Servs, Raises Price Target to $325

Benzinga·05/29/2026 15:38:36
Listen to the news
Morgan Stanley analyst Kallum Titchmarsh maintains West Pharmaceutical Servs (NYSE:WST) with a Equal-Weight and raises the price target from $315 to $325.